“But Is It Safe?”
Of all the questions I hear about hormone therapy, this is the one that comes up most.
Sometimes it’s asked directly.
Sometimes it’s asked quietly, after a long pause:
“Won’t it give me breast cancer?”
It’s a completely fair question. And it deserves a real answer, not a dismissive “you’ll be fine” or a fearful “never touch it.”
So let me be clear about something before we go any further.
This post isn’t here to talk you into hormone therapy.
It’s here to help you understand the risks, the benefits, and the questions worth asking, so that whatever you decide, you decide with real information.
Where the Fear Comes From
If you’re afraid of hormone therapy, you’re not being irrational. You’re responding to what you were told.
In 2002, early results from the Women’s Health Initiative (WHI) made headlines linking hormone therapy to breast cancer, heart disease, and stroke. Almost overnight, millions of women stopped treatment. Many providers stopped prescribing it.
The next year, a boxed warning (the FDA’s most serious kind) was added to every estrogen product, regardless of dose, type, or how it was delivered.
A whole generation of women grew up hearing one message: hormones cause cancer.
What got far less attention was the nuance. The women studied were, on average, in their 60s and often many years past menopause. The study used specific hormone formulations. And some of the findings, as we’ll see, pointed in a very different direction.
Fear spreads quickly. Nuance takes a lot longer.
What the Research Shows Now
More than two decades of follow-up have given us a much clearer picture.
Estrogen alone and estrogen plus a synthetic progestin behaved differently. In long-term WHI follow-up published in JAMA in 2020, women with a prior hysterectomy who took estrogen alone had a lower rate of breast cancer and lower breast cancer deaths than women on placebo. Women who took estrogen combined with a synthetic progestin (medroxyprogesterone acetate) had a higher rate of breast cancer. [1]
The type of progestogen may matter. Large observational studies from France (the E3N cohort) suggested a lower breast cancer risk with micronized progesterone, the body-identical form, than with some synthetic progestins. Several menopause societies point to this data, while noting it needs more confirmation. [2]
Timing matters. Women who start hormone therapy within about 10 years of menopause, generally before age 60, tend to have the most favorable balance of benefits and risks. [3]
And the FDA has changed its stance. In November 2025, the FDA announced it was removing most of the boxed warning from menopausal hormone therapy products, including the breast cancer language. The warning about endometrial cancer risk with estrogen alone in women who still have a uterus remains. [3][4]
That’s a significant shift. But it doesn’t mean hormone therapy is risk-free. It means the conversation is finally becoming more accurate.
Let’s Name the Risks Honestly
You deserve the full picture, so here it is.
Breast cancer. Combined estrogen and progestogen therapy has been linked to a small increase in breast cancer risk, which appears to grow with longer use. A large 2019 analysis in The Lancet also found some elevated risk can persist for years after stopping. [5]
Endometrial cancer. If you still have a uterus, estrogen on its own can thicken the uterine lining. That’s why a progestogen is added for protection.
Blood clots and stroke. Oral estrogen is associated with an increased risk of blood clots. Transdermal estrogen (patches, gels, sprays) appears to carry a lower clot risk.
Side effects. Breast tenderness, bloating, spotting, or mood changes can happen, especially early on or while finding the right dose.
These risks are real.
They’re also individual. They depend on your age, how far you are from menopause, your personal and family history, which hormones you use, the dose, and how they’re delivered.
That’s why “Is hormone therapy safe?” is really two questions:
What are the risks in general?
And: What are the risks for me?
Why Many Women Decide It’s Worth It
Every medication carries some risk. The real question is always whether the benefits outweigh the risks for you.
For many women, hormone therapy can:
Relieve hot flashes and night sweats, often dramatically
Improve sleep
Ease vaginal dryness, painful sex, and some bladder symptoms
Help protect bone density and reduce fracture risk
Support mood and quality of life during a demanding season
And when started within about 10 years of menopause, randomized studies have shown a reduction in all-cause mortality and fractures. [3]
It also helps to remember that hormone therapy isn’t the only factor that affects breast cancer risk. Alcohol, excess weight after menopause, inactivity, and family history all play a role too.
For some women, the decision is easy. For others, it takes time.
Both are okay.
Questions to Bring to Your Provider
Whether you’re just curious or ready to start, these questions can make your appointment far more productive:
Based on my personal and family history, what is my baseline breast cancer risk?
Am I a good candidate for hormone therapy, given my age and how long it’s been since my last period?
Which hormones would you recommend for me, and why?
Would you use micronized progesterone or a synthetic progestin? What’s the difference for me?
Would you recommend a patch, gel, pill, or another delivery method?
What dose would we start with, and how will we adjust it?
What benefits can I realistically expect, and how soon?
What side effects should I watch for?
How will we monitor my breast health while I’m on hormones?
How often will we revisit whether this is still the right choice for me?
A good provider will welcome these questions.
If you feel rushed or dismissed when you ask them, that’s worth paying attention to.
What Monitoring Looks Like
Starting hormone therapy isn’t a one-and-done decision. It’s an ongoing conversation.
In my practice, monitoring typically includes:
Regular follow-ups, especially in the first few months, to check how you’re feeling and adjust the dose if needed
Staying current on mammograms and any other breast imaging recommended for you
Breast awareness at home, knowing what’s normal for you and reporting changes like a new lump, skin changes, or nipple discharge
Reporting unexpected bleeding, which always deserves evaluation
Lab work when it’s useful, interpreted alongside your symptoms
An annual check-in on whether hormone therapy is still the right fit as your health and goals change
You’re never locked in. You can always revisit the decision.
When Hormone Therapy Might Not Be for You
Hormone therapy isn’t right for everyone. And that’s okay.
Systemic hormone therapy is generally not recommended, or needs very careful consideration with your care team, if you have:
A personal history of breast cancer or another hormone-sensitive cancer
Unexplained vaginal bleeding that hasn’t been evaluated
A history of blood clots, stroke, or heart attack
Active liver disease
A known high genetic risk, such as a BRCA mutation, without guidance from a specialist
Some women may still have options, such as low-dose vaginal therapies, depending on their history. But those decisions should always be made individually and, when appropriate, with your oncologist or specialist.
And sometimes, hormone therapy isn’t for you simply because you don’t want it.
That’s a valid choice too. There are non-hormonal options and lifestyle strategies that can help, and you deserve support either way.
The Goal Is an Informed Choice
I’m not here to tell you hormone therapy is right for you.
I’m also not going to tell you it’s something to fear.
My job is to help you understand your own risks and benefits clearly, so you can make the decision that feels right for your body, your history, and your life.
You deserve honest answers.
You deserve time to ask questions.
And you deserve a choice that’s truly yours.
If you’d like to talk through whether hormone therapy makes sense for you, I’m here.
Always here for you,
Jenn
Sources
Chlebowski RT, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA. 2020;324(4):369-380.
British Menopause Society, International Menopause Society, et al. Joint statement on menopausal hormone therapy and breast cancer risk. 2020.
U.S. Department of Health and Human Services. Fact sheet: FDA initiates removal of "black box" warnings from menopausal hormone replacement therapy products. November 2025.
Elimination of the Black Box Warning on Menopausal Hormone Therapy. Obstetrics & Gynecology. 2026;147(5):642-646.
Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk. The Lancet. 2019;394:1159-1168.
